Qunrui Ye

Weatherford College — United States

Medicine · Health Sciences

15h-index2.5kcitations44works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(33), Immune Cell Function and Interaction(19), Immunotherapy and Immune Responses(18), Viral Infectious Diseases and Gene Expression in Insects(13), T-cell and B-cell Immunology(9)

Publications44 total

Editor's Note: <i>In Vivo</i> Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)
Cancer Research·2024Open Access
Supplementary Figure Legend from CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor
2023Open Access
Supplementary Table from CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor
2023Open Access
CCR Translation for This Article from CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor
2023Open Access
CCR Translation for This Article from CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor
2023Open Access
Data from CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor
2023Open Access
Supplementary Table from CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor
2023Open Access
Supplementary Figure Legend from CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor
2023Open Access
Supplementary Figs 1, 2 from CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor
2023Open Access
Data from CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor
2023Open Access
Supplementary Figs 1, 2 from CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor
2023Open Access
Supplementary Figures Legends 1-5 from &lt;i&gt;In Vivo&lt;/i&gt; Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)
2023Open Access
Supplementary Figure 1 from &lt;i&gt;In Vivo&lt;/i&gt; Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)
2023Open Access
Supplementary Figure 2 from &lt;i&gt;In Vivo&lt;/i&gt; Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)
2023Open Access
Supplementary Methods and Materials from &lt;i&gt;In Vivo&lt;/i&gt; Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)
2023Open Access
Supplementary Figure 4 from &lt;i&gt;In Vivo&lt;/i&gt; Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)
2023Open Access
Supplementary Figure 1 from &lt;i&gt;In Vivo&lt;/i&gt; Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)
2023Open Access
Data from &lt;i&gt;In Vivo&lt;/i&gt; Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)
2023Open Access
Supplementary Figure 2 from &lt;i&gt;In Vivo&lt;/i&gt; Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)
2023Open Access
Supplementary Figure 4 from &lt;i&gt;In Vivo&lt;/i&gt; Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Mathilde Poussin(31), George Coukos(30), De-Gang Song(29), Mariangela Figini(19), Daniel J. Powell(18), Carl H. June(17), Carmine Carpenito(16), Chunyan Ji(16), Liping Wang(15), Daniel J. Powell(12), Tori N. Yamamoto(10), Andrew Best(10), Daniel Powell(7), Wayne W. Hancock(5), Chunsheng Li(5), De-Gang Song(4), Andrew Best(4), Liqing Wang(4), Rongxiang Han(4), Chunsheng Li(3)